What’s Driving Growth in the Analgesics Market? Insights into Key Trends and Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the analgesics market size evolved in recent years?
In the past few years, there has been a consistent growth in the size of the analgesics market. It is projected to expand from a value of $109.97 billion in 2024 to a worth of $113.96 billion in 2025, evidencing a compound annual growth rate (CAGR) of 3.6%. The growth experienced in the historic period is due to factors such as the influence of alternative therapies, results of safety and efficacy studies, prevalence of pain, marketing and promotional activities, and economic considerations.
What are the predictions for the analgesics market size in the coming years?
The market size of retail ready packaging is projected to undergo significant growth in the coming years, expanding to a value of $134.97 billion in 2029 with an expected compound annual growth rate (CAGR) of 9.5%. Factors influencing this growth trend in the forecasted period include the ongoing demand for efficiency, requirements for e-commerce packaging, branding through custom packaging, environmental considerations, and the integration of automation. Key trends anticipated during this period are a focused approach to minimizing packaging waste, the incorporation of intelligent packaging technologies, the emergence of e-commerce compatible packaging alternatives, the growing popularity of upright pouches and adaptable packaging, as well as innovative designs in shelf-ready packaging.
Get your analgesics market report here!
https://www.thebusinessresearchcompany.com/report/analgesics-global-market-report
What key factors are fueling the growth of the analgesics market?
The escalation of chronic disease prevalence is propelling the analgesics market. Analgesic medications, also known as pain relievers, are utilized to alleviate and lessen severe or chronic body pain resulting from various health conditions. For example, a report shared by the Switzerland-based health organization WHO, stated in September 2022 that chronic diseases, also referred to as noncommunicable diseases (NCDs), are conditions that evolve over a prolonged span of time due to a blend of genetic, physiological, environmental, and behavioral factors. Noncommunicable diseases result in 41 million deaths each year, accounting for 74% of global fatalities. Every year, 17 million people die from an NCD before reaching the age of 70. These premature deaths represent 86% of the total deaths in low- and middle-income countries, with 77% NCD-related fatalities occurring in such nations. Consequently, the surge in chronic disease prevalence is fuelling the expansion of the analgesics market.
How is the global analgesics market divided into key segments?
The analgesics market covered in this report is segmented –
1) By Type: Non-opioids, Opioids
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Drug Stores
3) By Application: Internal Analgesics, External Analgesics
Subsegments:
1) By Non-Opioids: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Acetaminophen (Paracetamol), Salicylates
2) By Opioids: Natural Opioids, Semi-Synthetic Opioids, Synthetic Opioids
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2438&type=smp
Who are the key firms paving the way for growth in the analgesics market?
Major companies operating in the analgesics market include Pfizer Inc., Johnson & Johnson Services Inc., Medley Pharmaceuticals Limited, AbbVie Inc., Bayer HealthCare Pharmaceuticals LLC, Novartis International AG, Sanofi SA, Bristol-Myers Squibb Co., AstraZeneca Plc., Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical company Limited, Eli Lilly and Company, Reckitt Benckiser Group plc, Viatris Inc., Teva Pharmaceuticals Industries Ltd., Sun Pharmaceutical Industries Limited, Purdue Pharma L.P, Cipla Limited, Allergan Inc., Endo International plc, Amneal Pharmaceuticals LLC, Mallinckrodt Pharmaceuticals Ltd., Chattem Inc., Hisamitsu Pharmaceutical Co.Inc., GW Pharmaceuticals, Verve Health Care Ltd., Alder BioPharmaceuticals Inc., Achelios Therapeutics Inc., WEX Pharmaceuticals Inc., Zynerba Pharmaceuticals, McNeil Consumer & Specialty Medical Products, Innovative Med Concepts LLC
Which trends are expected to transform the analgesics market?
The analgesics market is witnessing a surge in companies investing as a growth strategy. Major drug manufacturers in the analgesics market are directing their funds into clinical-stage companies, thereby enhancing their competitive edge and solidifying their market stand. Such financial involvement supports companies to widen their global reach and acquire specialized knowledge in the invention and development of novel products. For example, in January 2022, Concentric Analgesics, Inc., a clinical-stage biopharmaceutical corporation based in the US, confirmed the finalization of a $20 million convertible note financing sourced from a diverse group of new and continuing investors. The proceeds of this funding will kick start the registration-enabling Phase 3 tests for Vocacapsaicin, their leading product candidate that is prepared for Phase 3. It will also be used to sustain additional Phase 3 development tasks for Vocacapsaicin, the top medical choice of Concentric Analgesics for treating post-surgical discomfort. The wrap-up of this financing process marks a significant milestone for Concentric Analgesics as it paves the way for the company to persist in driving Vocacapsaicin into Phase 3 development and can be considered the crucial initial move towards fully financially supporting the program up to NDA submission.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2438
What regions are contributing significantly to the growth of the analgesics market?
North America was the largest region in the analgesics market in 2024. Middle East is expected to be the fastest-growing region in the global analgesics market during the forecast period. The regions covered in the analgesics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
COVID-19 Detection Test Kits and Consumables Global Market Report 2024
COVID-19 Drug Associated APIs Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/covid19-drug-associated-api-global-market-report
Dermatology Medical Lasers Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/dermatology-medical-lasers-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: